Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe with Benralizumab Administered at Home

Trial Identifier: D3250C00029
Sponsor: AstraZeneca
NCTID:: NCT02417961
Start Date: April 2015
Primary Completion Date: March 2016
Study Completion Date: March 2016
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Canada, AB Calgary, AB, Canada
Canada, BC Vancouver, BC, Canada
Canada, ON Ajax, ON, Canada
Canada, ON Burlington, ON, Canada
Canada, ON Mississauga, ON, Canada
Canada, ON Toronto, ON, Canada
Canada, QC Pointe-Claire, QC, Canada
Canada, QC Quebec, QC, Canada
Canada, QC Quebec City, QC, Canada
Canada, QC St Charles Borromee, QC, Canada
Canada, QC Trois-Rivières, QC, Canada
United States of America, CA Fountain Valley, CA, United States of America
United States of America, CA Walnut Creek, CA, United States of America
United States of America, FL Celebration, FL, United States of America
United States of America, FL Ocala, FL, United States of America
United States of America, FL Orlando, FL, United States of America
United States of America, FL Winter Park, FL, United States of America
United States of America, GA Albany, GA, United States of America
United States of America, MN Minneapolis, MN, United States of America
United States of America, MO St Louis, MO, United States of America
United States of America, NE Bellevue, NE, United States of America
United States of America, TX San Antonio, TX, United States of America